Short-course antibiotic therapy-replacing constantine units with “shorter is better”.
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
(See the Major article by Fernandez-Lazaro et al on pages 1467–75.) Ten years ago, Dr Lou Rice gave a keynote address at the annual meeting of the Infectious Diseases Society of America [1]. In his address, Dr Rice pointed out that treating bacterial infections for only as long as necessary was probably the safest and most achievable means to reduce unnecessary antibiotic use [1]. He also pointed out that many traditional antibiotic courses are unnecessarily long. Indeed, durations of antibiotic therapy for most bacterial infections are based on the fact that the week has 7 days in it, resulting in traditional 7- to 14-day antibiotic courses [2]. And the modern week has 7 days in it because the Roman Emperor Constantine the Great said so in 321 CE [2]. Had Constantine chosen a 4-day week, providers would likely routinely prescribe 4- to 8-day courses of therapy. Fortunately, in the last 25 years, clinical investigators have clarified necessary antibiotic durations by conducting over 40 randomized controlled trials (RCT) comparing short course vs traditional courses of antibiotics for a variety of bacterial infections (Table 1). Interestingly, in many cases, the short-course regimens were not based on “Constantine units” of duration. In every RCT thus far published for the diseases shown in Table 1, short-course therapy was just as effective as longer courses and often with better point estimates of clinical success, fewer adverse events, and/or diminished emergence of resistance at the site of infection [2–5]. Diseases for Which Short-course Antibiotic Therapy Has Been Found to Be Equally Effective to Longer Traditional Courses of Therapy (With References) Diseases for Which Short-course Antibiotic Therapy Has Been Found to Be Equally Effective to Longer Traditional Courses of Therapy (With References) Based on such a potent tour de force of data, one might expect short-course therapy to have become the standard of care in the decade since Dr Rice’s keynote address. Alas, however, a recent study found that only 1 in 3 Infectious Diseases specialists recommend short-course regimens across many countries [32]. The rate is likely lower among providers of other specialties, who prescribe by far the majority of antibiotics. In this issue of Clinical Infectious Diseases, Fernandez-Lazaro et al add to our knowledge of who is, or is not, prescribing short-course antibiotic regimens [33]. They conducted an exhaustive retrospective study of 5.6 million outpatient antibiotic courses prescribed by 10 616 Family Medicine specialists in Ontario, Canada, from March 2016 to February 2017. Unfortunately, the authors found that the median duration of antibiotic regimens was 7–8 days (38%), less than 25% of prescriptions were shorter than 7 days, and substantially more than 30% were for longer than 8 days. Such long durations of therapy are unlikely warranted for most routine bacterial infections treated with outpatient oral antibiotics. The authors deemed courses longer than 8 days to be “prolonged” and sought to determine factors associated with prescribing prolonged courses of therapy. An important limitation of the study was the inability to link individual prescriptions to clinical diagnoses. For most infections treated with oral outpatient therapy, it is likely that even 7–8 days of therapy were excessive (Table 1). Thus, the results are a conservative estimate of the overprescription of antibiotics. In a sign of hope for the future, by multivariate analysis, the authors found that early career physicians (<11 years since graduation from medical school) were significantly less likely to prescribe prolonged courses than mid- or late-career physicians. Late-career physicians (≥25 years since medical school) did the worst. Other factors associated with prolonged courses included practice in a rural setting, patients with more comorbidities, and patients who cared for proportionately more children. One might speculate that practicing in rural areas (where follow-up and continuity might be more limited), or caring for patients with more comorbidities, and/or more children, imparts a greater sense of risk and fear to the provider, resulting in a more conservative approach to antibiotic prescriptions (eg, longer courses of therapy). The fact that physicians with more years of practice tended to prescribe longer courses may reflect training in the previous era of tremendous hubris regarding the invincibility of antibiotics [34, 35] and prior to any notions or systematic implementation of antimicrobial stewardship. The improved prescribing practices of younger physicians offer the hope that as older physicians who have not adapted to changes in evidenced-based medicine retire, overall prescribing practices will improve. However, younger physicians should beware of their own hubris, because they still more often than not prescribed unnecessarily long courses of antibiotics. Furthermore, as mentioned, the expert who first publicly
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Restricting antimicrobial therapy to the shortest course associated with better outcomes is an important part of antimicrobial stewardship [281–285].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [285]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Meeker, D., Linder, J. A., Fox, C. R., Friedberg, M. W., Persell, S. D., Goldstein, N. J., Knight, T. K., Hay, J. W., & Doctor, J. N. (2016) · JAMA · doi:10.1001/jama.2016.0275 · Cited by 860
Trial of short-course antimicrobial therapy for intraabdominal infection.
Sawyer, R. G., Claridge, J. A., Nathens, A. B., Rotstein, O. D., Duane, T. M., Evans, H. L., Cook, C. H., O’Neill, P. J., Mazuski, J. E., Askari, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411162 · Cited by 747
Interventions to improve antibiotic prescribing practices in ambulatory care
Arnold, S. R., & Straus, S. E. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003539.pub2 · Cited by 713
The Future of Antibiotics and Resistance
Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1215093 · Cited by 647
Self-citationBernard, L., Dinh, A., Ghout, I., Simo, D., Zeller, V., Issartel, B., Le Moing, V., Belmatoug, N., Lesprit, P., Bru, J.-P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61233-2 · Cited by 494
Yahav, D., Franceschini, E., Koppel, F., Turjeman, A., Babich, T., Bitterman, R., Neuberger, A., Ghanem-Zoubi, N., Santoro, A., Eliakim-Raz, N., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1054 · Cited by 433 · cited 1×
“Gram-negative bacteremia [25] 7 14 Equal”
Prokocimer, P., De Anda, C., Fang, E., Mehra, P., & Das, A. (2013) · JAMA · doi:10.1001/jama.2013.241 · Cited by 361
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Optimizing antibiotic therapies to reduce the risk of bacterial resistance
Bassetti, S., Tschudin-Sutter, S., Egli, A., & Osthoff, M. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.01.029 · Cited by 196
Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review
Wald‐Dickler, N., Holtom, P. D., Phillips, M. C., Centor, R. M., Lee, R. A., Baden, R. P., & Spellberg, B. J. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.10.007 · Cited by 171
Self-citationDuration of antibiotic therapy: shorter is better
Spellberg, B., & Rice, L. B. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1509 · Cited by 155
“Fortunately, in recent years, more than 45 randomized controlled trials (RCTs) have compared the efficacy of short-course versus traditional, longer courses of antibiotic therapy for the treatment of communityacquired and nosocomial pneumonia, acute exacerbation of chronic bronchitis and sinusitis, complicated urinary…”
InfluentialSelf-citationPernica, J. M., Harman, S., Kam, A. J., Carciumaru, R., Vanniyasingam, T., Crawford, T., Dalgleish, D., Khan, S. H., Slinger, R., Fulford, M., et al. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.6735 · Cited by 154
Environmental Antimicrobial Resistance: Implications for Food Safety and Public Health
Ifedinezi, O. V., Nnaji, N. D., Anumudu, C. K., Ekwueme, C. T., Uhegwu, C. C., Ihenetu, F. C., Obioha, P., Simon, B. O., Ezechukwu, P. S., & Onyeaka, H. N. (2024) · Antibiotics · doi:10.3390/antibiotics13111087 · Cited by 121
Brown, K. A., Langford, B. J., Schwartz, K. L., Diong, C. C., Garber, G. E., & Daneman, N. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa124 · Cited by 120
Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations
Morrisette, T., Kebriaei, R., Lev, K. L., Morales, S., & Rybak, M. J. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2358 · Cited by 110
Oral or intravenous antibiotics?
McCarthy, K. L., & Avent, M. L. (2020) · Australian Prescriber · doi:10.18773/austprescr.2020.008 · Cited by 97
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Morrisette, T., Miller, M. A., Montague, B. T., Barber, G. R., McQueen, R. B., & Kršák, M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz162 · Cited by 95
Davar, K., Clark, D. C., Centor, R. M., Dominguez, F., Ghanem, B., Lee, R. Z. Y., Lee, T. C., McDonald, E. G., Phillips, M. C., Sendi, P., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac706 · Cited by 90
Self-citationEvidence of Antibiotic Resistance from Population-Based Studies: A Narrative Review
Giacomini, E., Perrone, V., Alessandrini, D., Paoli, D., Nappi, C., & Esposti, L. D. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s289741 · Cited by 79
Same, R. G., Amoah, J., Hsu, A. J., Hersh, A. L., Sklansky, D. J., Cosgrove, S. E., & Tamma, P. D. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa055 · Cited by 72
Duration of antibiotic therapy for common infections
Grant, J., & Saux, N. L. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2021-04-29 · Cited by 58
Lewis, J. M., Mphasa, M., Banda, R. L., Beale, M. A., Heinz, E., Mallewa, J., Jewell, C., Faragher, B. E., Thomson, N. R., & Feasey, N. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01216-7 · Cited by 49
Antibiotic therapy for severe bacterial infections
Timsit, J., Ling, L., de Montmollin, É., Bracht, H., Morris, A. C., Bus, L. D., Falcone, M., Harris, P. N. A., Machado, F. R., Paiva, J.-A., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08063-0 · Cited by 47
Goff, D. A., Mangino, J. E., Trolli, E., Scheetz, R., & Goff, D. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac361 · Cited by 41
Tamma, P. D., Miller, M. A., Dullabh, P., Ahn, R., Speck, K. A., Gao, Y., Scherpf, E., & Cosgrove, S. E. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0235 · Cited by 39
The Shorter Is Better movement: past, present, future
Spellberg, B. J., & Rice, L. B. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.005 · Cited by 35
Self-citationHyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality
Martín-Fernández, M., Heredia‐Rodríguez, M., González-Jiménez, I., Lorenzo‐López, M., Gómez‐Pesquera, E., Poves‐Álvarez, R., Alvarez, E., Jorge-Monjas, P., Beltrandeheredia, J., Gutiérrez‐Abejón, E., et al. (2022) · Critical Care · doi:10.1186/s13054-021-03875-0 · Cited by 32
Surapat, B., Montakantikul, P., Malathum, K., Kiertiburanakul, S., Santanirand, P., & Chindavijak, B. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05312-z · Cited by 32
Phillips, M. C., Wald‐Dickler, N., Loomis, K. J., Luna, B. M., & Spellberg, B. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa460 · Cited by 26
Self-citationMachine learning and synthetic outcome estimation for individualised antimicrobial cessation
Bolton, W., Rawson, T. M., Hernandez, B., Wilson, R. C., Antcliffe, D. B., Georgiou, P., & Holmes, A. H. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.997219 · Cited by 26
Cespedes, J. M. Z., Zafrilla, P., Ballester, P., & Cerdá, B. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s375125 · Cited by 25
Howard-Anderson, J. R., Dai, W., Yahav, D., Hamasaki, T., Turjeman, ., Koppel, F., Franceschini, E., Hill, C. B., Sund, Z. M., Chambers, H. F. “., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac140 · Cited by 24
Hospital Discharge: An Opportune Time for Antimicrobial Stewardship
Parsels, K. A., Kufel, W. D., Burgess, J. L., Seabury, R. W., Mahapatra, R., Miller, C. D., & Steele, J. M. (2021) · Annals of Pharmacotherapy · doi:10.1177/10600280211052677 · Cited by 22
Venugopalan, V., Hamza, M., Santevecchi, B. A., DeSear, K., Cherabuddi, K., Peloquin, C. A., & Al‐Shaer, M. H. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac171 · Cited by 21
Elshenawy, R. A., Umaru, N., & Aslanpour, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17030339 · Cited by 20
Applying the Infectious Diseases Literature to People who Inject Drugs
Serota, D. P., Chueng, T. A., & Schechter, M. C. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.06.010 · Cited by 20
Goss, F. R., Bookman, K. J., Barron, M. A., Bickley, D., Landgren, B., Kroehl, M., Williamson, K. M., Zane, R. D., & Wiler, J. L. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12029 · Cited by 19
Imlay, H. N., & Spellberg, B. J. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13896 · Cited by 18
Self-citationAlegria, W., Marini, B. L., Gregg, K., Bixby, D. L., Perissinotti, A. J., & Nagel, J. L. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7054 · Cited by 16
Evaluation of OPAT in the Age of Antimicrobial Stewardship
Mahoney, M. V. G., Ryan, K. L., & Alexander, B. T. (2020) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-020-00217-6 · Cited by 16
Blondeau, J. M., & Fitch, S. D. (2021) · Microorganisms · doi:10.3390/microorganisms9112279 · Cited by 16
Harvey, E. J., McLeod, M. C., Brún, C. D., & Ashiru-Oredope, D. A. I. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068299 · Cited by 15
Exploring the etiology of colitis: insights from gut microbiota research
Qian, G., Chen, X., Liu, G., Yu, J., Zhong, S.-J., Yang, J., Sun, Y., & Zhou, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2512010 · Cited by 15
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Cantón, R., Barberán, J., Linares, M., Molero, J., González-Moro, J. M. R., Salavert, M., & del Castillo, J. M. G. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/172.2021 · Cited by 15
Description of antibiotic use variability among US nursing homes using electronic health record data
Kabbani, S., Wang, S. W., Ditz, L., Gouin, K. A., Palms, D. L., Rowe, T. A., Hyun, D. Y., Chi, N. W., Stone, N. D., & Hicks, L. A. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.207 · Cited by 14
How to change the course: practical aspects of implementing shorter is better
Domínguez, F., Gaffin, N., Davar, K., Wald‐Dickler, N., Minejima, E., Werge, D., Holtom, P. D., Spellberg, B. J., & Baden, R. P. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.07.025 · Cited by 13
Self-citationFarrell, S., BAĞCIGİL, A. F., Chaintoutis, S. C., Firth, C. L., Aydın, F. G., Hare, C. H. Z., Maaland, M. G., Mateus, A., Vale, A. P., Windahl, U., et al. (2023) · The Veterinary Journal · doi:10.1016/j.tvjl.2023.106045 · Cited by 13
Attias, N., Schlaeffer‐Yosef, T., Zahavi, I., Hasson, N., Ari, Y. B., Darawsha, B., Levitan, I., Goldberg, E., Landes, M., Litchevsky, V., et al. (2024) · Infection · doi:10.1007/s15010-024-02445-0 · Cited by 13
Janssen, R. M. E., Oerlemans, A. J. M., van der Hoeven, J. G., Oostdijk, E. A. N., Derde, L. P. G., ten Oever, J., Wertheim, H. F. L., Hulscher, M., & Schouten, J. A. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154363 · Cited by 12
Short-course antibiotic therapy: The next frontier in antimicrobial stewardship
Sheppard, D. C. (2022) · Canada Communicable Disease Report · doi:10.14745/ccdr.v48i1112a01 · Cited by 12
Monday, L., Yazdanpaneh, O., Sokolowski, C., Chi, J., Kuhn, R., Bazzy, K., & Dhar, S. (2021) · Global Journal on Quality and Safety in Healthcare · doi:10.36401/jqsh-21-2 · Cited by 12
Buis, D. T. P., van Werkhoven, C. H., van Agtmael, M. A., Bax, H. I., Berrevoets, M. A. H., de Boer, M., Bonten, M. J. M., Bosmans, J. E., Branger, J., Douiyeb, S., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068295 · Cited by 11
Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review
Dimopoulou, D., Moschopoulos, C. D., Dimopoulou, K., Dimopoulou, A., Berikopoulou, M. M., Andrianakis, I. A., Tsiodras, S., Kotanidou, Α., & Fragkou, P. C. (2024) · Antibiotics · doi:10.3390/antibiotics13111078 · Cited by 10
Determining the Appropriateness of Initiating Antibiotic Therapy in Nursing Home Residents
Mylotte, J. M. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.06.034 · Cited by 10
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic
Rivera, C. G., Mahoney, M. V. G., Stevens, R. W., & Saleh, O. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa309 · Cited by 9
Nursing Home-Associated Pneumonia, Part II: Etiology and Treatment
Mylotte, J. M. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.01.012 · Cited by 9
Florence Nightingale and Antimicrobial Stewardship
Olans, R. D., Olans, R. N., & DeMaria, A. (2022) · Florence Nightingale Journal of Nursing · doi:10.5152/fnjn.2022.21141 · Cited by 9
Arns, B., Kalil, A. C., Sorio, G. G. L., Boschi, E., Antônio, A. C. P., Antonio, J. P., Birriel, D. C., Lanziotti, D. H., Abbott, F. D. C., Rocha, G. C., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05178-6 · Cited by 8
Wright, W. F., Bejou, N., Shields, R. K., Marr, K. A., McCarty, T. P., & Pappas, P. G. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00512-19 · Cited by 8
Khumra, S., Mahony, A. A., Bergen, P. J., & Elliott, R. A. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14734 · Cited by 8
Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
Mandell, L. A., Zhanel, G. G., Rotstein, C., Muscedere, J., Loeb, M. B., & Johnstone, J. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac043 · Cited by 7
Eguizabal, L. A., de Tobillas, I. C.-M., Melgosa-Latorre, F., Domingo‐Echaburu, S., Losada, A. U., Eguiluz-Pinedo, A., Rodriguez-Piacenza, N. V., & Ibarrondo, O. (2022) · Antibiotics · doi:10.3390/antibiotics11101336 · Cited by 7
Chen, G., Li, W., Zhao, Y., Cui, Y., Song, C., Li, H., Liu, B., Li, Y., & Pan, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-26212-9 · Cited by 6
Shively, N. R., Jacobs, M. W., Moffa, M. A., Schorr, R. E., & Walsh, T. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac458 · Cited by 6
Prager, M., Bergmann, F., Pracher, L., Copic, D., Zessner‐Spitzenberg, J., Gelbenegger, G., Lagler, H., Harrison, N. M., Burgmann, H., Zeitlinger, M. A., et al. (2025) · Infection · doi:10.1007/s15010-025-02562-4 · Cited by 5
A step further: Antibiotic stewardship programme in home hospital
Núñez, L. M., Fernández, C. G., Muñoz, M. R., Álvarez, J. C., Griñó, C. J., Callejero, Á. P., Fernández, E. P., Anglada, I. G., & García, J. E. L. (2024) · Infectious Diseases Now · doi:10.1016/j.idnow.2024.105008 · Cited by 5
Arns, B., Horvath, J. D. C., Rech, G. S., Sesin, G. P., Agani, C. A. J. O., da Rosa, B. S., dos Santos, T. M., Brochier, L. S. B., Cavalcanti, A. B., Tomazini, B. M., et al. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00897-9 · Cited by 5
Reyes, S., Morel-Almonte, M., Kostka, J., & Nicolau, D. P. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000756 · Cited by 5
Short Versus Long Antibiotic Duration in Streptococcus pneumoniae Bacteremia
Crotty, M. P., Devall, H., Cook, N., Fischer, F., Alexander, J., Hunter, L., & Dominguez, E. A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae478 · Cited by 5
Galimam, S., Panozzo, B., Muir, K., & Chavada, R. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07117-8 · Cited by 5
Utility of Procalcitonin in Clinical Practice
Aurón, M., & Seymann, G. (2023) · Journal of Brown Hospital Medicine · doi:10.56305/001c.81280 · Cited by 5
Luu, T., Fan, A., Shaw, R. C., Dalal, H., Adams, J., Santarossa, M., Reid, G., Tsai, S., Clark, N. M., & Albarillo, F. S. (2024) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_192_23 · Cited by 5
CE: Pediatric Antibiotic Stewardship
Good, A. R., & Olans, R. D. (2021) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000798052.41204.18 · Cited by 4
Short-course Antibiotic Therapy: A Bespoke Approach Is Required
Hughes, S., Kamranpour, P., Gibani, M. M., Mughal, N., & Moore, L. S. P. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz711 · Cited by 4
Evaluating the duration of antimicrobial therapy for the treatment of orthopedic hardware infections
Asim, R., Fuchs, C. J., & Summers, N. A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01269-24 · Cited by 4
Pong, S., Fowler, R., Murthy, S., Pernica, J. M., Gilfoyle, E., Fontela, P. S., Rishu, A. H., Mitsakakis, N., Hutchison, J. S., Science, M. E., et al. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03219-z · Cited by 3
Cox, H., Roeder, F., Okell, L., Niles-Robin, R. A., James, K., Valz, O., Hauck, K., & Sicuri, E. (2024) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2024.109 · Cited by 3
Rodríguez-Molino, P., Mellado-Sola, I., López, J. G. D. Á., Baquero‐Artigao, F., Díaz‐Almirón, M., Moreno‐Pérez, D., Calvo, C., & Escosa‐García, L. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106805 · Cited by 3
Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time
Gallagher, J. C. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad013 · Cited by 3
Shortening the Duration of Therapy for Staphylococcus aureus Bacteremia: Opening the Overton Window
Tong, S. Y. C., & Walls, G. B. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab205 · Cited by 3
Alim, M., & Kirmizi, N. Ö. (2025) · BMC Oral Health · doi:10.1186/s12903-025-06262-1 · Cited by 3
Tamma, P. D., Miller, M. A., & Cosgrove, S. E. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-484ip · Cited by 3
Dam, T. A., Schade, R. P., de Steenwinkel, J. E. M., Otten, M., Roggeveen, L. F., Hoogendoorn, M., Girbes, A. R. J., Fleuren, L. M., & Elbers, P. (2025) · Journal of Critical Care · doi:10.1016/j.jcrc.2025.155247 · Cited by 3
Perera, D., Vogrin, S., Khumra, S., Motaganahalli, S., Batrouney, A., Urbancic, K. F., Devchand, M., Mitri, E. A., Clements, R., Nunn, A. K., et al. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad111 · Cited by 3
SWITCH ORAL DE ANTIMICROBIANOS EM PACIENTES HOSPITALIZADOS: REVISÃO DE ESCOPO
Santos, L. K. B., Sousa, D. D. S., dos Santos, B. S. P., Silva, M. C. F. E., Lopes, A. M., & Dourado, C. S. D. M. E. (2024) · Revista Interfaces Saúde Humanas e Tecnologia · doi:10.16891/2317-434x.v12.e1.a2024.pp3955-3965 · Cited by 2
Procalcitonin Is Not an Adequate Tool for Antimicrobial De-Escalation in Sepsis
Maves, R. C. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004547 · Cited by 2
Perceval, L. M., Wargny, M., Benhamida, M., Dumortier, M., Guen, C. G., Navas, D., & Launay, E. (2025) · Archives de Pédiatrie · doi:10.1016/j.arcped.2025.02.002 · Cited by 2
Practicing With Intent: How to Teach an Old Dogma New Tricks
Phillips, M. C., Davar, K., Freling, S., Tong, S. Y. C., Lee, T. C., McDonald, E. G., Nielsen, T. B., Wald‐Dickler, N., Lora, A. J. M., Lee, R. A., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf270 · Cited by 2
Self-citationDuration of antibiotic therapy of the most common bacterial infections
Štefan, M. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.057 · Cited by 1
Reply to MacFadden and Hanage and to Pallett et al
Paul, M., Yahav, D., Mussini, C., & Leibovici, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz105 · Cited by 1
Shinohara, K., Tochitani, K., Katada, Y., Murata, T., Morita, M., Tsuda, Y., Tsuchido, Y., Yamamoto, M., Matsumura, Y., & Nagao, M. (2026) · Infection · doi:10.1007/s15010-026-02938-0 · Cited by 1
Fernandez-Lazaro, C. I., Langford, B. J., & Schwartz, K. L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz713 · Cited by 1
‘’Myth Busting in Infectious Diseases’’: A Comprehensive Review
Almajid, A., Almuyidi, S., Alahmadi, S., Bohaligah, S., Alfaqih, L., Alotaibi, A., Almarzooq, A., Alsarihi, A., Alrawi, Z., Althaqfan, R., et al. (2024) · Cureus · doi:10.7759/cureus.57238 · Cited by 1
The Invisible Excess: Too Long Antibiotic Duration in the Pediatric Emergency Care
Molina-Gutiérrez, M. Á., Camacho-Gil, M., Rojo, V. S., & Escosa‐García, L. (2026) · Antibiotics · doi:10.3390/antibiotics15020128 · Cited by 1
Adherence of Spanish pediatricians to “do not do” guidelines to avoid low-value care in pediatrics
Pérez, R. P., Sangrador, C. O., López-Martín, D., Martínez-Campos, L., Calvo, C., Soriano, B. J. N., & the Working Group of Ambulatory Management Infections of the Spanish Society of Pediatric Infectious Diseases (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04613-6 · Cited by 1
Cespedes, J. M. Z. (2023) · RIUCAM · Cited by 1
Mahoney, M. V. G. (2021) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000993 · Cited by 1
Exploring Antibiotic Utilization in Assisted Living: Identifying Opportunities for Improvement
Ford, J. H., Liao, C.-Y., & Crnich, C. J. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.03.023 · Cited by 1
Ito, H., Ogawa, Y., Ogawa, R., Shimojo, N., & Kawano, S. (2022) · Infectious Diseases Now · doi:10.1016/j.idnow.2022.02.007 · Cited by 1
Spellberg, B. J., & Wald‐Dickler, N. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz712
Self-citationDetermining Appropriateness of Antibiotic Therapy in Nursing Home Residents: A ReviewPreprint
Mylotte, J. M. (2022) · Qeios · doi:10.32388/zjukul
Determining Appropriateness of Antibiotic Therapy in Nursing Home Residents: A ReviewPreprint
Mylotte, J. M. (2022) · Qeios · doi:10.32388/zjukul.2
Bush, L. M. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737399005.793584407
80/m mit Dyspnoe und zunehmender Verwirrtheit: Vorbereitung auf die Facharztprüfung: Fall 18
Draenert, R. (2021) · Der Internist · doi:10.1007/s00108-020-00934-6
Pereira, J. M., DIAS, H. I., Ciarlini, N. D. S. C., de Albuquerque, J. S. A., TIMBÓ, F. J., NETO, F. C., Chaves, E. F., & Nobre, K. S. S. (2022) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2022.131.0720
Metadata
- Authors
- Wald-Dickler, N., & Spellberg, B.
- Affiliations
- Los Angeles County and University of Southern California (LAC+USC) Medical Center, Los Angeles
- University of Southern California (US)
- Corresponding author
- Spellberg, Brad
- ORCID
- Spellberg, Brad
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-07
- Volume
- 69
- Issue
- 9
- Pages
- 1476-1479
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC6792080
- OpenAlex
- W2909383354
- Cited by
- 117
- References
- 49
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 18 · 2023: 13 · 2022: 28 · 2021: 22 · 2020: 13 · 2019: 8
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI130060, R01 AI117211, R21 AI132923)
- National Institutes of Health
- Agency for Healthcare Quality Research (R01 HS025690)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Surgery › Surgical site infection prevention
- Keywords
- short-course antibiotic therapy, antibiotic duration, antibiotic prescribing patterns, general practice, antimicrobial resistance, unnecessary antibiotic use, bacterial infection, prescribing recommendations, antimicrobial stewardship, treatment failure rate, antibiotic costs, patient satisfaction with treatment duration
- MeSH terms
- Anti-Bacterial Agents, Drug Administration Schedule, Humans, Physicians, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.